SCHEMBL23309531

SCHEMBL23309531

O=C(Nc1ccc(Cl)c(F)c1)c1cc(F)nc(F)c1F

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.49
▸ NPC1 O15118 6/20 0.47
▸ RAB9A P51151 6/20 0.47
▸ CD38 P28907 1/20 0.46
▸ KCNQ3 O43525 2/20 0.46
▸ KCNQ2 O43526 2/20 0.46
▸ KCNE1 P15382 2/20 0.46
▸ KCNQ1 P51787 2/20 0.46
▸ KCNQ5 Q9NR82 1/20 0.45
▸ FADS1 O60427 1/20 0.44
▸ GRM4 Q14833 3/20 0.44
▸ NPY1R P25929 1/20 0.44
▸ NPY2R P49146 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ HPGD P15428 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SLC2A1 P11166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309495 0.89 FADS1 (0.56) MAOBNPC1RAB9AFADS1MAPT
SCHEMBL23309703 0.87 RAB9A (0.51) MAOBNPC1RAB9ACD38KCNQ3
SCHEMBL23309730 0.85 KMT2A (0.47) MAOBNPC1RAB9AMAPTKMT2A
SCHEMBL23309708 0.85 RAB9A (0.52) NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL23309539 0.84 NPC1 (0.52) NPC1RAB9ANPY1RNPY2RMAPT
SCHEMBL23309702 0.84 ALDH1A1 (0.55) NPC1RAB9AKCNQ3KCNQ2KCNE1
SCHEMBL23309546 0.82 NFKB1 (0.50) NPC1RAB9AFADS1NPY1RNPY2R
SCHEMBL23309502 0.81 NFKB1 (0.51) MAOBNPC1RAB9AFADS1MAPT
SCHEMBL23309548 0.81 FADS1 (0.55) MAOBNPC1RAB9AFADS1GRM4
SCHEMBL23309533 0.81 ALDH1A1 (0.43) NPC1RAB9AGRM4MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL MAOB 2341/4885NPC1 412/4885RAB9A 286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback